| 1 马云，付香斌，李芬，等. 哺乳动物类血管生长因子基因(ANGPTL)的研究进展［J］. 信阳师范学院学报，2008, 21(3)：474～477. 2 丰胜求. 猪ANGPTL家族基因的克隆表达及调控研究［D］.武汉：华中农业大学, 2006.3 柳明洙, 高圭永. 血管生成素及其相关蛋白的研究进展［J］. 生命科学研究, 2001, 5(3): 202～211.4 Farhat N, Thorin-Trescases N, Mamarbachi M, et al. Angiopoietin-like 2 promotes atherogenesis in mice［J］. J Am Heart Assoc, 2013, 2(3): e000201.5 Horton J D, Bashmakov Y, Shimomura I, et al. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice ［J］. Proc Natl Acad Sci USA, 1998, 95(11): 5987～5992.6 Horton J D, Goldstein J L, Brown M S. SREBPs:Activators of the complete program of cholesterol and fatty acid synthesis in the liver［J］. J Clin Invest, 2002, 109(9): 1125～1131.7 Iizuka K, Bruick R K, Liang G, et al. Deficiency of carbohydrate response element-binding protein(ChREBP) reduces lipogenesis as well as glycolysis［J］. Proc Natl Acad Sci USA, 2004, 101(19):7281～7286.8 Kaplan R, Zhang T, Hernandex M, et al. Regulation of the angiopoietin-like protein 3 gene by LXR ［J］. J Lipid, 2003, 44(1):136～143.9 Kuriyama H, Liang G, Engelking L J, et al. Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver［J］. Cell Metab，2005, 1(1):41～51.10 Musunuru K, Pirruccello J P, Do R, et al. Exome sequencing,ANGPTL3 mutations,and familial combined hypolipidemia［J］. N Engl J Med, 2010, 363(23): 2220～2227.11 Ono M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3(ANGPTL3): ANGPTL3 is cleaved and activated in vivo［J］. J Biol Chem, 2003, 278(43): 41804～41809.12 Quagliarinia F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3［J］. PNAS, 2012, 109(27):19751～19756.13 Ren G, Kim J Y, Smas C M. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism［J］. Am J Physiol Endocrinol Metab, 2012, 303(3): E334～E351.14 Robciuc M R, Maranghi M, Lahikainen A, et al. ANGPTL3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids ［J］. Arterioscler Thromb Vasc Biol, 2013, 33(7): 1706～1713.15 Romeo S, Pennacchio L A, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers varia-tions that reduce triglycerides and increase HDL［J］. Nat Genet, 2007, 39(4): 513～516.16 Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans［J］. J Clin Invest, 2009, 119(1): 70～79.17 Shan L, Yu X C, Liu Z Y, et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms ［J］. J Biol Chem, 2009, 284(1): 1419～1424.18 Shimamura M, Matsuda M, Yasumo H, et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase［J］. Arterioscler Thromb Vasc Biol, 2007, 27(2): 366～372.19 Steckman A K, Towle H C.The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression［J］. J Biol Chem, 2002, 277(30): 27029～27035.20 Wang Y, Quagliarini F, Gusarova V, et al. Mice lacking ANGPTL8(Betatrophin) manifest disrupted triglyceride metabolism without inpaired glucose homeostasis ［J］. Proc Natl Acad Sci USA, 2013, 110(40): 16109～16114.21 Yin W, Romeo S, Chang S, et al. Genetic variation in ANGPTL4 provides insights into protein processing and function ［J］. J Biol Chem, 2009, 284(19): 13213～13222.22 Yi P, Park J S, Melton D A. Betatrophin: A hormone that controls pancreatic β cell proliferation ［J］. Cell, 2013, 153(4):747～758.23 Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels ［J］. Biochem Biophys Res Commun, 2012, 424(4): 786～792. |
